These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 16555161)
1. [Inhibitory effect of angiogenesis inhibitor YH-16 in combination with 5-FU on liver metastasis of colorectal cancer]. Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Tang SX; Ye YL; Chen G; Lin SX Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Mar; 9(2):161-4. PubMed ID: 16555161 [TBL] [Abstract][Full Text] [Related]
2. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer]. Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270 [TBL] [Abstract][Full Text] [Related]
3. [Effect of angiogenesis inhibitor SU6668 on the growth and metastasis of gastric cancer in SCID mice]. Jiang XT; Tao HQ; Zou SC Zhonghua Wei Chang Wai Ke Za Zhi; 2006 Jul; 9(4):335-7. PubMed ID: 16886118 [TBL] [Abstract][Full Text] [Related]
4. [Inhibition of bladder cancer cell growth and angiogenesis by co-blockage of vascular endothelial growth factor and its receptor KDR]. Chen XL; Liu LC; Xu ZG; Li Z; Li RW; Gao RJ; Wang S; Zhang M; Guo H Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):578-82. PubMed ID: 19102933 [TBL] [Abstract][Full Text] [Related]
5. Combination therapy of interferon-alpha and 5-fluorouracil inhibits tumor angiogenesis in human hepatocellular carcinoma cells by regulating vascular endothelial growth factor and angiopoietins. Wada H; Nagano H; Yamamoto H; Arai I; Ota H; Nakamura M; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Doki Y; Dono K; Nakamori S; Sakon M; Monden M Oncol Rep; 2007 Oct; 18(4):801-9. PubMed ID: 17786339 [TBL] [Abstract][Full Text] [Related]
6. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice]. Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793 [TBL] [Abstract][Full Text] [Related]
7. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells. Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341 [TBL] [Abstract][Full Text] [Related]
8. [Inhibitory effects of transfection of arresten gene on liver metastasis from colorectal cancer in nude mice]. Long MY; Li HH; Xu JY; Lai DM; Weng ZH Ai Zheng; 2008 Oct; 27(10):1039-43. PubMed ID: 18851782 [TBL] [Abstract][Full Text] [Related]
9. [Effect of Endostatin and SU6668 combined with 5-FU on human colon cancer xenograft in nude mice]. Zeng QL; Chu ZH; Zhou K; Luo XJ Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):376-8. PubMed ID: 18636363 [TBL] [Abstract][Full Text] [Related]
10. [Effect of anti-vascular endothelial growth factor antibody on the progression of human gastric cancer orthotopic xenotransplanted into nude mice]. Tao H; Lin Y; Yin H; Yao M Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):248-50. PubMed ID: 11829834 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of angiogenesis and intrahepatic growth of colon cancer by TAC-101. Murakami K; Sakukawa R; Sano M; Hashimoto A; Shibata J; Yamada Y; Saiki I Clin Cancer Res; 1999 Sep; 5(9):2304-10. PubMed ID: 10499597 [TBL] [Abstract][Full Text] [Related]
12. A novel, orally administered nucleoside analogue, OGT 719, inhibits the liver invasive growth of a human colorectal tumor, C170HM2. Rohlff C; Watson SA; Morris TM; Skelton L; Jackman AL; Page MJ Cancer Res; 1999 Mar; 59(6):1268-72. PubMed ID: 10096558 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of growth and metastases of human colon cancer xenograft in nude mice by angiogenesis inhibitor endostatin]. Zhang GF; Wang YH; Zhang MA; Wang Q; Luo YB; Wang DS; Han CR Ai Zheng; 2002 Jan; 21(1):50-3. PubMed ID: 12500397 [TBL] [Abstract][Full Text] [Related]
14. [Effect of vascular endothelial growth factor antibody Avastin on angiogenesis of human gastric cancer growing orthotopically in nude mice]. Wang N; Wang B; Wang YJ Ai Zheng; 2006 Sep; 25(9):1076-81. PubMed ID: 16965645 [TBL] [Abstract][Full Text] [Related]
15. Effects of the combination of hyperbaric oxygen and 5-fluorouracil on proliferation and metastasis of human nasopharyngeal carcinoma CNE-2Z cells. Peng ZR; Zhong WH; Liu J; Xiao PT Undersea Hyperb Med; 2010; 37(3):141-50. PubMed ID: 20568543 [TBL] [Abstract][Full Text] [Related]
16. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma. Tachimori A; Yamada N; Amano R; Ohira M; Hirakawa K Anticancer Res; 2008; 28(2A):629-38. PubMed ID: 18507001 [TBL] [Abstract][Full Text] [Related]
18. The potential for a selective cyclooxygenase-2 inhibitor in the prevention of liver metastasis in human colorectal cancer. Yamauchi T; Watanabe M; Hasegawa H; Nishibori H; Ishii Y; Tatematsu H; Yamamoto K; Kubota T; Kitajima M Anticancer Res; 2003; 23(1A):245-9. PubMed ID: 12680220 [TBL] [Abstract][Full Text] [Related]
19. Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Lee L; Sharma S; Morgan B; Allegrini P; Schnell C; Brueggen J; Cozens R; Horsfield M; Guenther C; Steward WP; Drevs J; Lebwohl D; Wood J; McSheehy PM Cancer Chemother Pharmacol; 2006 Jun; 57(6):761-71. PubMed ID: 16172907 [TBL] [Abstract][Full Text] [Related]
20. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities. Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]